Company intelligence / Profile preview

Home Biosciences

Paris, Île-de-France, Francehomebiosciences.com ↗

Ownership: Private
Development stage: Other

Overview

Home Biosciences operates as a biotech venture builder, creating and supporting multiple asset-centric companies focused on developing transformative medicines in areas of high unmet need. Its portfolio includes projects such as One Biosciences (single-cell/AI-driven oncology) and Sequantrix (anti-fibrotic therapies), both leveraging advanced technologies to identify novel drug targets. Clinical results are early-stage or preclinical; no late-stage data reported yet.

Therapeutic areas: Rare DiseasesOncologyOther
Modalities: Small moleculeBiologicmRNA-based drugsAntibody
Industry: Biotech

Partnerships

Institut Curie collaboration with One BiosciencesRedmile GroupSofinnova Partners

Beyond the preview

Go deeper on Home Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Home Biosciences.

Explore the full profile